论文部分内容阅读
巯甲丙脯酸(captopril,以下简称CPT)是一种血管紧张素转换酶抑制剂。应用于治疗充血性心力衰竭,近几年来在国内外已有不少报道,但在治疗小儿难治性充血性心力衰竭方面,国内尚未见系统报道。我院儿科1985年5月至1986年2月用CPT治疗小儿难治性充血性心力衰竭11例,临床疗效满意,现报道如下。临床资料一、一般资料:本组患儿11例,男7例,女4例。年龄:37天～14岁,其中～3岁4例,～6岁3例,～14岁4例。原发疾病:先天性心脏病7例(大型室间隔缺损3例,复杂心脏畸型2例,法乐氏四联
Captopril (captopril, hereinafter referred to as CPT) is an angiotensin converting enzyme inhibitor. Application in the treatment of congestive heart failure, in recent years there have been many reports at home and abroad, but in the treatment of refractory congestive heart failure in children, the domestic system has not yet been reported. Pediatric hospital from May 1985 to February 1986 with CPT in children with refractory congestive heart failure in 11 cases, the clinical efficacy is satisfactory, are reported below. Clinical data First, the general information: The group of 11 children, 7 males and 4 females. Age: 37 days to 14 years, of which ~ 3 years old in 4 cases, ~ 6 years in 3 cases, ~ 14 years in 4 cases. Primary disease: 7 cases of congenital heart disease (large ventricular septal defect in 3 cases, 2 cases of complex cardiac malformations, tetralogy of Fallot